Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5826
United States 12 Month Oil Fund,
USL
$51.9M
| $189K | ﹤0.01% |
4,159
| – | – |
2013 Q2
52 quarters
|
|
5827
Corbus Pharmaceuticals
CRBP
$85.3M
| $188K | ﹤0.01% |
20,093
-12,761
| -39% | -$121K |
2015 Q2
44 quarters
|
|
5828
Teucrium Corn Fund
CORN
$121M
| $188K | ﹤0.01% |
11,234
+1,693
| +18% | +$30.3K |
2024 Q1
9 quarters
|
|
5829
iShares MSCI Philippines ETF
EPHE
$132M
| $188K | ﹤0.01% |
7,781
-4,748
| -38% | -$118K |
2013 Q2
52 quarters
|
|
5830
iShares iBonds Dec 2031 Term Muni Bond ETF
IBMT
$156M
| $188K | ﹤0.01% |
7,284
+972
| +15% | +$25K |
2025 Q4
2 quarters
|
|
5831
JPMorgan Sustainable Municipal Income ETF
JMSI
$362M
| $187K | ﹤0.01% |
3,709
| – | – |
2023 Q3
11 quarters
|
|
5832
Soluna Holdings
SLNH
$176M
| $186K | ﹤0.01% |
137,558
+133,885
| +3,645% | +$194K |
2021 Q2
20 quarters
|
|
5833
Apyx Medical
APYX
$108M
| $186K | ﹤0.01% |
41,337
-10,290
| -20% | -$40.8K |
2016 Q2
40 quarters
|
|
5834
Surrozen
SRZN
$279M
| $186K | ﹤0.01% |
7,151
-15,295
| -68% | -$420K |
2022 Q3
15 quarters
|
|
5835
Nautilus Biotechnolgy
NAUT
$275M
| $184K | ﹤0.01% |
98,212
+48,709
| +98% | +$129K |
2020 Q3
23 quarters
|
|
5836
Terra Innovatum Global N.V.
NKLR
$286M
| $184K | ﹤0.01% |
37,303
+22,086
| +145% | +$125K |
2025 Q4
2 quarters
|
|
5837
Alpha Architect US Quantitative Momentum ETF
QMOM
$431M
| $183K | ﹤0.01% |
2,330
+87
| +4% | +$6.7K |
2024 Q3
7 quarters
|
|
5838
T. Rowe Price Dividend Growth ETF
TDVG
$1.31B
| $183K | ﹤0.01% |
3,739
+1,253
| +50% | +$59.3K |
2024 Q1
9 quarters
|
|
5839
GBank Financial Holdings
GBFH
$241M
| $183K | ﹤0.01% |
6,041
-3,681
| -38% | -$107K |
2025 Q2
4 quarters
|
|
5840
Amplify Bloomberg AI Equal Weight ETF
AIVC
$132M
| $183K | ﹤0.01% |
1,586
| – | – |
2017 Q4
34 quarters
|
|
5841
Veritone
VERI
$53.8M
| $183K | ﹤0.01% |
133,549
-147,549
| -52% | -$282K |
2017 Q2
36 quarters
|
|
5842
Manhattan Bridge Capital
LOAN
$39.1M
| $182K | ﹤0.01% |
40,256
+1
| +0% | +$4 |
2018 Q2
32 quarters
|
|
5843
Arq
ARQ
$84.3M
| $181K | ﹤0.01% |
71,153
-44,875
| -39% | -$111K |
2016 Q3
39 quarters
|
|
5844
Yiren Digital
YRD
$56.8M
| $180K | ﹤0.01% |
215,716
+2,366
| +1% | +$3.91K |
2015 Q4
42 quarters
|
|
5845
SCHMID Group N.V. Warrants
SHMDW
| $180K | ﹤0.01% |
100,070
+71,090
| +245% | +$125K |
2026 Q1
1 quarter
|
|
5846
T. Rowe Price Blue Chip Growth ETF
TCHP
$2.18B
| $180K | ﹤0.01% |
3,593
-253
| -7% | -$12.6K |
2024 Q3
7 quarters
|
|
5847
eHealth
EHTH
$19.5M
| $180K | ﹤0.01% |
120,703
+700
| +0.6% | +$1.17K |
2013 Q2
52 quarters
|
|
5848
NEOS Nasdaq-100 Hedged Equity Income ETF
QQQH
$402M
| $180K | ﹤0.01% |
3,216
| – | – |
2021 Q1
21 quarters
|
|
5849
RiverNorth Capital and Income Fund
RSF
$49.3M
| $179K | ﹤0.01% |
12,263
+1
| +0% | +$15 |
2021 Q1
21 quarters
|
|
5850
Fidelity Disruptive Automation ETF
FBOT
$212M
| $179K | ﹤0.01% |
4,522
| – | – |
2023 Q2
12 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.